ARMISTICE CAPITAL, LLC purchased 0.3% of their position (140K shares) of AVALO THERAPEUTICS, INC. on the open market
Open‑market purchase worth $111.8K — a small addition. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 2/28/2022ACC: 0000899243-22-008145
Director10% Owner
Since Jun 2018
+140K
Net shares
Net buyer
$111.8K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
140K acquired
Non-Derivative Transactions2
Common Stock
Indirect
Shares
+100K
Price / share
$0.80
Trade value
$80.09K
% of position
0.2%
2/24/2022
46.70M→46.80M
Common Stock
Indirect
Shares
+40K
Price / share
$0.79
Trade value
$31.72K
% of position
0.1%
2/25/2022
46.80M→46.84M
Total
Net shares
+140K
Net value
$111.81K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 2/24/2022 | P · Purchase | +100K | $0.80 | $80.09K | 0.2% | 46.70M | 46.80M |
| Common Stock Indirect | 2/25/2022 | P · Purchase | +40K | $0.79 | $31.72K | 0.1% | 46.80M | 46.84M |
| Total | +140K | $111.81K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
DirectShares owned412.44K
Total
412.44K direct412.44K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 412.44K | Direct |
| Total | 412.44K | 412.44K direct |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported